September 02, 2014 10:30 AM ET

Pharmaceuticals

Company Overview of Ascenta Therapeutics, Inc.

Executive Profile

Marc Estes Lippman M.D.

Co-Founder and Director, Ascenta Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 2 Board Members in 2 different organizations across 4 different industries.

See Board Relationships
69--

Background

Dr. Marc Estes Lippman is the Co-Founder of Ascenta Therapeutics, Inc. and serves as its Director. Dr. Loppman was a Senior Advisor of Perseus, L.L.C. He joined it in 1995. Dr. Lippman is a Deputy Director of The Sylvester Comprehensive Cancer Center since January 2010. He serves as the Chairperson of the Scientific Advisory Board for the Perseus-Soros Fund. In addition, Dr. Lippman serves as a Scientific and Clinical Advisor at Threshold Pharmaceuticals Inc. He has ...

Corporate Headquarters

101 Lindenwood Drive
Malvern, Pennsylvania 19355

United States

Phone: 610-408-0301
Fax: 610-725-1515

Board Members Memberships

Director
Former Member of Clinical Advisory Board
Co-Founder and Director
2000-Present
Director

Education

BA 1964
Cornell University
MD
Yale University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Ascenta Therapeutics, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.